CA9 and neoplasm: This relationship is evidenced by data from patients' tumor specimens derived from diverse tissue types, where CA IX is often correlated, co-expressed and/or spatially overlapped with the biomarkers of glycolytic metabolism (including MCT1, MCT4, and LDH5) and with glucose consumption rate determined by 18FDG-PET (34–36).